A comparison of serum and tissue hCGβ as prognostic markers in colorectal cancer

Anticancer Research

Volumn 20, Issue 6 D, 2000, Pages 4949-4951

  Lundin, M ^a   Nordling, S ^a   Carpelan Holmstrom, M ^a   Louhimo, J ^a   Alfthan, H ^a   Stenman, U H ^a   Haglund, C ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Colorectal cancer; HCG ; Prognosis

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ACCURACY; ADULT; AGED; ASSAY; CANCER SURVIVAL; COLORECTAL CANCER; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TISSUE LEVEL; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034450624     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Glycoprotein hormones: Structure and function
2. Biological markers in breast carcinoma. II. Clinical correlations with human chorionic gonadotrophin
3. Ectopic production of chorionic gonadotropin and its subunits by islet- cell tumors. A specific marker for malignancy
4. An immunohistochemical study of the significance of HCG secretion by large bowel adenocarcinomata
5. Immunohistochemical expression of beta-human chorionic gonadotropin in colorectal carcinoma
6. Human chorionic gonadotropin in colorectal carcinoma. An immunohistochemical study
7. Human chorionic gonadotrophin expression in colorectal adenocarcinoma
8. Human chorionic gonadotropin in colorectal cancer and its relationship to prognosis
9. The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9 and C-erb B- 2, beta HCG immunohistochemistry in advanced colorectal cancer
10. The prognostic value of human chorionic gonadotropin expression in colorectal adenocarcinomas. An immunohistochemical study of 102 stage B2 and C2 nonmucinous adenocarcinomas
11. Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer
12. Choriogonadotropin and its beta subunit separated by hydrophobic- interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays
13. Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women
14. Tumor-associated antigens in polyps and carcinoma of the human large bowel
15. The incidence and significance of serum hCG and CEA in patients with gastrointestinal malignant tumors
16. Ectopic production of human chorionic gonadotrophin by neoplasms
17. Human chorionic gonadotrophins (hCG) in non-trophoblastic neoplasms. Assessment of abnormalities of hCG and CEA in bronchogenic and digestive neoplasms
18. The clinical application of a specific radioimmunoassay for human chorionic gondotropin in trophoblastic and nontrophoblastic tumors
19. Free human chorionic gonadotropin beta subunit in gonadal and nongonadal neoplasms
20. Multiple markers of malignancy in sera patients with colorectal carcinoma: Preliminary clinical studies
21. The serum levels of human alpha-fetoprotein, AFP, choriogonadotropin, hCG, placental lactogen, hPL, and pregnancyspecific beta 1- glycoprotein, SP1, are of no clinical significance in colorectal carcinoma
22. Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous-cell carcinoma of the oral cavity and oropharynx